查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678732

全球性行为感染自我检测市场：市场规模、份额、趋势分析（按应用和地区）、细分市场预测（2025-2030 年）

STD Self-Testing Market Size, Share & Trends Analysis Report By Application (CT/NG Testing, Syphilis Testing, HIV Testing), By Region (North America, Asia Pacific, Europe, Latin America, MEA), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

性行为感染传染病自我检测市场的成长与趋势：

根据 Grand View Research, Inc. 的一份新报告，全球性行为感染传染病 (STD) 自我检测市场预计到 2030 年将达到 19.8 亿美元。

预计 2025 年至 2030 年期间市场复合年增长率为 8.75%。对隐私和便利性的不断增长的需求是性行为感染自我检测市场的主要驱动力。性传染病的耻辱感和对保密的担忧常常使人们不愿意去诊所，特别是在较小的社区或那些医疗保健有限的社区。自我检测套组可以让人们轻鬆地在家中进行检测并进行私下检测，而无需去诊所。线上订购测试的便利性和快速、可靠的结果极大地促进了自我测试解决方案的采用，尤其是在重视健康管理自主权和保密性的年轻群体中。随着人们寻求更个人化和更​​轻鬆的医疗保健选择，预计这一趋势将继续推动市场发展。

此外，性行为感染感染发生率的不断上升预计将极大地推动性行为感染自我检测市场的发展，因为这凸显了对更容易获得、更有效的解决方案的需求。随着全球爱滋病毒、披衣菌感染、梅毒和淋病病例的增加，公共卫生系统越来越重视早期发现和预防策略。自我检测套组提供了一种实用的解决方案，使个人可以私下进行检测并快速获得治疗。人们越来越意识到定期进行性病检测的重要性，加上在家中进行检测的便利性，推动了这些产品的需求。随着性行为感染传染病的持续蔓延，对更快捷、更谨慎、更用户友好的选择的需求可能会推动自我检测市场的进一步成长。

此外，多个国家政府的大力支持以及主要产业参与者对开发性传染感染套件的策略性倡议正在推动市场成长。例如，伯内特研究所与 Atomo Diagnostics 公司共同开发了一种活动性梅毒快速检测方法，由澳洲政府资助 244 万美元，成为性行为感染自我检测市场的主要市场驱动力。横向流动测试使用指尖采血样本和梅毒抗体检测，提供了专业和家庭自我检测选项，使测试更容易、更方便和更谨慎。这些快速、易于使用的诊断技术的创新正在加速套件的采用，有助于满足对更快、更可靠的性病检测解决方案的需求，从而推动更广泛的市场成长。

性行为感染传染病自我检测市场：分析概述

  • 到 2024 年，CT/NG 检测部分将成为性行为感染自我检测市场中最大的收益部分。这是因为此类感染疾病在世界各地流行率很高。披衣菌感染和淋病是最常见的性行为感染传染病，对快速、便捷的检测有着巨大的需求。
  • 这些感染疾病的自我检测套组的采用越来越多，再加上易于使用且准确的诊断解决方案，进一步加强了 CT/NG 领域在市场上的主导地位。
  • 由于对早期检测和预防的需求不断增加，预计预测期内爱滋病毒检测领域将成长最快。随着人们对爱滋病毒及其影响的认识不断提高，越来越多的人开始寻求在家中谨慎、方便的选择。
  • 此外，爱滋病毒快速自我检测的进步和政府支持措施也促进了这一领域的快速成长。
  • 由于先进的医疗基础设施、强大的宣传活动以及消费者对便利的家庭检测解决方案的需求不断增长，预计北美将在 2024 年引领全球市场。该地区对早期检测的关注，加上监管支援和技术创新，进一步推动了市场主导。

目录

第一章 分析方法及范围

第 2 章执行摘要

第 3 章。性行为感染传染病自我检测市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 性行为感染传染病自我检测市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析

第 4 章。性行为感染传染病自我检测市场：按应用进行的估计和趋势分析

  • 性行为感染传染病自我检测市场：按应用分類的仪表板
  • 性行为感染传染病自我检测市场：按应用进行的变化分析
  • 性行为感染自我检测市场按应用划分（以收益为准）
  • 沙眼披衣菌/淋病奈瑟菌 (CT/NG) 检测
  • 梅毒检测
  • HIV 检测
  • 其他的

第五章性行为感染传染病自我检测市场：按地区分類的估计和趋势分析

  • 区域控制面板
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争格局

  • 最新趋势和影响分析：按主要製造商
  • 公司/竞争对手分类
  • 供应商概况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 主要企业市场占有率分析（2024年）
    • OraSure Technologies, Inc.
    • Selfdiagnostics
    • Wondfo
    • bioLytical Laboratories
    • autotest VIH
    • Abbott
    • Visby Medical
    • PrivaPath Diagnostics（LetsGetChecked）
    • NOWDiagnostics
Product Code: GVR-4-68040-521-9

STD Self-Testing Market Growth & Trends:

The global STD self testing market size is expected to reach USD 1.98 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.75% from 2025 to 2030. The growing demand for privacy and convenience is a key driver for the STD self-testing market, as individuals seek more discreet and accessible ways to monitor their sexual health. Many people are hesitant to visit clinics due to the stigma associated with STDs and concerns about confidentiality, especially in smaller communities or regions with limited healthcare access. Self-test kits, which offer the convenience of being taken at home, allow users to test privately without the need for clinical visits. The ease of ordering tests online and receiving quick, reliable results has significantly contributed to adopting self-testing solutions, especially among younger populations who value autonomy and confidentiality in managing their health. This trend is expected to continue driving the market as individuals seek more personalized and hassle-free healthcare options.

In addition, the rising prevalence of STDs is expected to significantly drive the STD self-testing market, as increasing infection rates underscore the need for more accessible and efficient solutions. With cases of HIV, chlamydia, syphilis, and gonorrhea rising globally, public health systems are increasingly focused on early detection and prevention strategies. Self-testing kits offer a practical solution, enabling individuals to test in the privacy of their homes and seek treatment promptly. The growing awareness of the importance of regular STD testing, combined with the convenience of at-home diagnostics, is fueling demand for these products. As STDs continue to spread, the need for faster, discreet, and user-friendly options will drive further growth in the self-testing market.

Moreover, strong support from government of several countries and strategic initiatives undratken by industry's leading players to develop kits for STI's fuel the growth of the market. For instance, the collaboration between Burnet Institute and Atomo Diagnostics on the development of a rapid active syphilis test, backed by USD 2.44 million in funding from the Australian Government, highlights a key market driver for the STD self-testing market. This lateral flow test, which uses a finger prick blood sample and a syphilis antibody assay, offers both professional and at-home self-test options, making testing more accessible, convenient, and discreet. Such innovations in rapid and user-friendly diagnostic technologies are accelerating the adoption of kits, driving growth in the broader market by meeting the demand for quicker and more reliable STD test solutions.

STD Self-Testing Market Report Highlights:

  • In 2024, the CT/NG Testing segment was the largest revenue-generating sector of the STD self testing market. This is attributed to the high prevalence of these infections globally. Both Chlamydia and Gonorrhea are among the most commonly reported sexually transmitted infections, driving significant demand for rapid, accessible testing.
  • The increasing adoption of self-test kits for these infections, coupled with easy-to-use and accurate diagnostic solutions, further solidifies the dominance of the CT/NG segment in the market.
  • HIV Testing segment is expected to grow the fastest during the forecast period due to the rising demand for early detection and prevention. With increasing awareness about HIV and its impact, more people are seeking discreet, convenient options at home.
  • The advancement in rapid HIV self-tests and government-backed initiatives are also contributing to the segment's rapid growth, offering users quick, reliable results in a private setting.
  • The North American region is set to reign the global market in the year 2024 due to advanced healthcare infrastructure, strong awareness campaigns, and increasing consumer demand for convenient, at-home test solutions. The region's focus on early detection, coupled with regulatory support and innovation, further drives its market leadership.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. STD Self Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising STD prevalence
      • 3.2.1.2. Advancements in rapid diagnostic technology
      • 3.2.1.3. Supportive regulatory approvals & government initiatives
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Limited awareness and accessibility
  • 3.3. STD Self Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Environmental landscape

Chapter 4. STD Self Testing Market: Application Estimates & Trend Analysis

  • 4.1. Global STD Self Testing Market: Application Dashboard
  • 4.2. Global STD Self Testing Market: Application Movement Analysis
  • 4.3. Global STD Self Testing Market by Application , Revenue
  • 4.4. CT/NG Testing
    • 4.4.1. CT/NG testing market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Syphilis Testing
    • 4.5.1. Syphilis testing market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.6. HIV Testing
    • 4.6.1. HIV testing market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. STD Self Testing Market: Regional Estimates & Trend Analysis by Application and End Use

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.3.3. Mexico
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.6. Norway
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.3. India
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.4. Australia
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.6.2. Argentina
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.7.3. UAE
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.7.4. Kuwait
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2024
    • 6.3.4. OraSure Technologies, Inc.
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Selfdiagnostics
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Wondfo
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. bioLytical Laboratories
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. autotest VIH
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Abbott
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Visby Medical
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. PrivaPath Diagnostics (LetsGetChecked)
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. NOWDiagnostics
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 4 Global STD Self Testing, by Region, 2018 - 2030 (USD Billion)
  • Table 5 North America STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 6 North America STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 7 U.S. STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 8 Canada STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 9 Mexico STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 10 Europe STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 11 Europe STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 12 Germany STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 13 UK STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 14 France STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 15 Italy STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 16 Spain STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 17 Denmark STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 18 Sweden STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 19 Norway STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 20 Asia Pacific STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 21 Asia Pacific STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 22 China STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 23 Japan STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 24 India STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 25 South Korea STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 26 Australia STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 27 Thailand STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 28 Latin America STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 29 Latin America STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 30 Brazil STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 31 Argentina STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 32 Middle East & Africa STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 33 Middle East & Africa STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 34 South Africa STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 35 Saudi Arabia STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 36 UAE STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 37 Kuwait STD Self Testing, by Application, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 STD Self Testing Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global STD Self Testing Market, for Application, 2018 - 2030 (USD Billion)
  • Fig. 16 Global STD Self Testing Market, for CT/NG Testing, 2018 - 2030 (USD Billion)
  • Fig. 17 Global STD Self Testing Market, for Syphilis Testing, 2018 - 2030 (USD Billion)
  • Fig. 18 Global STD Self Testing Market, for HIV Testing, 2018 - 2030 (USD Billion)
  • Fig. 19 Global STD Self Testing Market, for Others, 2018 - 2030 (USD Billion)
  • Fig. 20 Regional Marketplace: Key Takeaways
  • Fig. 21 Regional Outlook, 2024 & 2030
  • Fig. 22 Global STD Self Testing Market: Region Movement Analysis
  • Fig. 23 North America STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 24 U.S. STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 25 Canada STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 26 Mexico STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 27 Europe STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 28 Germany STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 29 UK STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 30 France STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 31 Italy STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 32 Spain STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 33 Denmark STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 34 Sweden STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 35 Norway STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 36 Asia Pacific STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 37 Japan STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 38 China STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 39 India STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 40 Australia STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 41 South Korea STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 42 Thailand STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 43 Latin America STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 44 Brazil STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 45 Argentina STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 46 Middle East and Africa STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 47 South Africa STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 48 Saudi Arabia STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 49 UAE STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 50 Kuwait STD Self Testing Market, 2018 - 2030 (USD Billion)